Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
This precision-medicine approach is especially valuable for breast cancer survivors, who may have altered baseline metabolism from chemotherapy or radiation
Additional risk factors commonly present in patients prescribed GLP-1 receptor agonists include: Reduced physical activity and prolonged immobility Hypertension and other cardiovascular comorbidities Dyslipidaemia contributing to atherosclerosis Advanced age , as thrombotic risk increases with ageing Other important VTE risk factors include: Previous VTE or family history of clotting disorders Thrombophilia (inherited or acquired clotting disorders) Active cancer or cancer treatment Oestrogen-containing medications (HRT, combined oral contraceptives) Pregnancy and postpartum period Recent surgery, trauma or hospitalisation Long-haul travel with prolonged immobility Smoking When patients taking GLP-1 receptor agonists experience thrombotic events, it is important to consider these pre-existing risk factors as they often contribute significantly to clotting risk in this population
ensuring you get enough selenium supports your glutathione status
The GLP-1 and breast cancer guide covers the current evidence on the relationship between GLP-1 agonists and breast cancer risk, which is an area of active research
A lot of people experience enhanced blood flow and cardiovascular function as well
US$ 20.30
US$ 21.83
US$ 25.57
US$ 29.28
US$ 26.48
US$ 22.28
